Clinical Trials Insight: 700033614
Phase of Trial: Phase III
Latest Information Update: 11 Mar 2013
At a glance
- Drugs Atorvastatin/fenofibrate (Primary)
- Indications Lipid metabolism disorders
- Focus Registrational; Therapeutic Use
- Sponsors Veloxis Pharmaceuticals
- 11 Mar 2013 Status changed from planning to unconfirmed.
- 17 May 2008 This program is expected to begin patient enrolment in the second half of 2008.
- 15 May 2008 New trial record.